Design and Evaluation of Phyto-phospholipid Complexes of Selected Polyherbal Churna Extracts for Anticancer Activity
Open Access
- 30 May 2026
- journal article
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- p. 1361-1371
Abstract
Background: Cancer continues to be a global health problem today. Traditional chemotherapy, which is commonly used in the treatment of cancer, has problems like low bioavailability, systemic toxicity, and drug resistance. Polyherbal formulations provide synergistic therapeutic advantages, whereas phyto-phospholipid complexation improves the solubility, permeability, and bioavailability of phytoconstituents. Aim: To develop and evaluate phyto-phospholipid complexes from a specific polyherbal churna extract that includes Picrorhiza kurroa, Bauhinia variegata, and Curcuma longa to boost their anticancer effects. Methods: A hydroalcoholic extract of polyherbal churna was prepared by maceration. Phyto-phospholipid complexes were prepared using the solvent evaporation method at different drug-phospholipid ratios (1:1, 1:2, and 1:3). Particle size analysis, Fourier Transform Infrared Spectroscopy (FTIR), X-Ray Diffraction (XRD), Digital Signature Certificate (DSC), and zeta potential determination were used to characterise the optimised complex. The DPPH and ABTS tests were used to see how well the antioxidants worked. The MTT assay was used to assess how toxic the cells were to HeLa, MCF-7, and A549 cancer cell lines. Results: Enhanced solubility and entrapment efficiency of 78.45 ± 2.3% were demonstrated by the optimised phyto-phospholipid complex (1:2 ratios). Complex formation was verified by FTIR and DSC. With IC50 values of 24.8 ± 1.5 μg/mL (DPPH) and 28.3 ± 1.8 μg/mL (ABTS), the complex outperformed crude extract in terms of antioxidant activity (IC50: 45.2 ± 2.1 and 52.6 ± 2.4 μg/mL, respectively). Comparing the complex to crude extract, cytotoxicity studies showed significantly lower IC50 values against MCF-7 (32.5 ± 2.1 μg/mL), HeLa (38.7 ± 2.5 μg/mL), and A549 (42.3 ± 2.8 μg/mL). Conclusion: Polyherbal churna extract phyto-phospholipid complexes showed increased antioxidant and cytotoxic potential, suggesting potential for cancer treatment and calling for additional in vivo research. Major Findings: The optimized complex (1:2 ratio) showed 5-fold enhanced solubility, 45% stronger antioxidant activity (IC₅₀: 24.8 vs 45.2 μg/mL), and two-fold improved cytotoxicity against cancer cell lines (IC₅₀: 32.5-42.3 vs 68.5-82.7 μg/mL) compared to crude extract, as confirmed by comprehensive characterization (FTIR, DSC, XRD, SEM, TEM).Keywords
This publication has 24 references indexed in Scilit:
- “Picrosides” from Picrorhiza kurroa as potential anti-carcinogenic agentsBiomedicine & Pharmacotherapy, 2019
- Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trialPharmacological Research, 2018
- RETRACTED: Phytosomal curcumin inhibits tumor growth in colitis‐associated colorectal cancerJournal of Cellular Physiology, 2018
- Self-assembled phospholipid-based phytosomal nanocarriers as promising platforms for improving oral bioavailability of the anticancer celastrolInternational Journal of Pharmaceutics, 2018
- Chemical composition, antioxidant and macromolecule damage protective effects of Picrorhiza kurroa Royle ex BenthSouth African Journal of Botany, 2014
- Transferrin mediated solid lipid nanoparticles containing curcumin: Enhanced in vitro anticancer activity by induction of apoptosisInternational Journal of Pharmaceutics, 2010
- The anti-oxidant activity of turmeric (Curcuma longa)Journal of Ethnopharmacology, 1995
- Immunostimulatory activity of Picrorhiza kurroa leaf extractJournal of Ethnopharmacology, 1994
- Potential anticancer activity of turmeric (Curcuma longa)Cancer Letters, 1985
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983